BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cha CH, Saif MW, Yamane BH, Weber SM. Hepatocellular carcinoma: Current management. Curr Probl Surg. 2010;47:10-67. [PMID: 19963083 DOI: 10.1067/j.cpsurg.2009.09.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Oger E, Lavenu A, Bellissant E, Garin E, Polard E. Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach. Pharmacoepidemiol Drug Saf 2011;20:956-63. [PMID: 21748824 DOI: 10.1002/pds.2177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bray SM, Vujanovic L, Butterfield LH. Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients. Clin Dev Immunol. 2011;2011:249281. [PMID: 21969837 DOI: 10.1155/2011/249281] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
3 Li F, Li X, Miao Y, Shan C, Yuan F, Ma C, Wang Q, Chen J, Chen Y. UHPLC-MS-based metabolomics analysis on mice bearing neoplasm (H22) for hispidulin. J Pharm Biomed Anal 2016;125:310-8. [PMID: 27077962 DOI: 10.1016/j.jpba.2016.03.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Vanpouille-Box C, Lacoeuille F, Roux J, Aubé C, Garcion E, Lepareur N, Oberti F, Bouchet F, Noiret N, Garin E. Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. PLoS One. 2011;6:e16926. [PMID: 21408224 DOI: 10.1371/journal.pone.0016926] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
5 Abouzed TK, Eldomany EB, Khatab SA, Aldhahrani A, Gouda WM, Elgazzar AM, Soliman MM, Kassab MA, El-Shazly SA, Althobaiti F, Dorghamm DA. The modulatory effect of bee honey against diethyl nitrosamine and carbon tetrachloride instigated hepatocellular carcinoma in Wistar rats. Toxicol Res (Camb) 2021;10:1092-103. [PMID: 34992771 DOI: 10.1093/toxres/tfab094] [Reference Citation Analysis]
6 Chan R, Kumar G, Abdullah B, Ng Kh, Vijayananthan A, Mohd Nor H, Liew Y. Optimising the scan delay for arterial phase imaging of the liver using the bolus tracking technique. Biomed Imaging Interv J 2011;7:e12. [PMID: 22287986 DOI: 10.2349/biij.7.2.e12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012;2012:421673. [PMID: 22655206 DOI: 10.5402/2012/421673] [Cited by in Crossref: 25] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
8 Sato K, Tanaka S, Mitsunori Y, Mogushi K, Yasen M, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: Clinical and biological significance. Hepatology 2013;57:1436-47. [DOI: 10.1002/hep.26122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chen Y, Liu S, Hou Z, Ma P, Yang D, Li C, Lin J. Multifunctional electrospinning composite fibers for orthotopic cancer treatment in vivo. Nano Res 2015;8:1917-31. [DOI: 10.1007/s12274-014-0701-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
10 Valdameri G, Trombetta-Lima M, Worfel PR, Pires AR, Martinez GR, Noleto GR, Cadena SM, Sogayar MC, Winnischofer SM, Rocha ME. Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells. Chem Biol Interact. 2011;193:180-189. [PMID: 21756884 DOI: 10.1016/j.cbi.2011.06.009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
11 Aquib M, Juthi AZ, Farooq MA, Ali MG, Janabi AHW, Bavi S, Banerjee P, Bhosale R, Bavi R, Wang B. Advances in local and systemic drug delivery systems for post-surgical cancer treatment. J Mater Chem B 2020;8:8507-18. [DOI: 10.1039/d0tb00987c] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Zhang Z, Kuang G, Zong S, Liu S, Xiao H, Chen X, Zhou D, Huang Y. Sandwich-Like Fibers/Sponge Composite Combining Chemotherapy and Hemostasis for Efficient Postoperative Prevention of Tumor Recurrence and Metastasis. Adv Mater 2018;30:1803217. [DOI: 10.1002/adma.201803217] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 15.8] [Reference Citation Analysis]
13 Wang M, Wei K, Qian B, Feiler S, Lemekhova A, Büchler MW, Hoffmann K. HSP70-eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2262. [PMID: 32823513 DOI: 10.3390/cancers12082262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Li WH, Ma KW, Cheng M, Chui KH, Chan PT, Chu WH, Fung HS, Kowk CH, Cheung MT. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010;80:714-21. [PMID: 21040332 DOI: 10.1111/j.1445-2197.2010.05434.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Liang L, Guan J, Zeng Y, Wang J, Li X, Zhang X, Ding Y. Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma. Hum Pathol 2011;42:1603-12. [PMID: 21496865 DOI: 10.1016/j.humpath.2010.08.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
16 Bu L, Yan J, Wang Z, Ruan H, Chen Q, Gunadhi V, Bell RB, Gu Z. Advances in drug delivery for post-surgical cancer treatment. Biomaterials 2019;219:119182. [DOI: 10.1016/j.biomaterials.2019.04.027] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
17 Tong H, Li X, Zhang CL, Gao JH, Wen SL, Huang ZY, Wen FQ, Fu P, Tang CW. Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. J Dig Dis 2013;14:29-37. [PMID: 23134145 DOI: 10.1111/1751-2980.12001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Giunchedi P, Maestri M, Gavini E, Dionigi P, Rassu G. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1. Expert Opin Drug Deliv 2013;10:679-90. [PMID: 23406440 DOI: 10.1517/17425247.2013.770733] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
19 Liu S, Wang X, Zhang Z, Zhang Y, Zhou G, Huang Y, Xie Z, Jing X. Use of asymmetric multilayer polylactide nanofiber mats in controlled release of drugs and prevention of liver cancer recurrence after surgery in mice. Nanomedicine: Nanotechnology, Biology and Medicine 2015;11:1047-56. [DOI: 10.1016/j.nano.2015.03.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
20 Cid MA, Ubeda A, Hernández-Bule ML, Martínez MA, Trillo MÁ. Antagonistic effects of a 50 Hz magnetic field and melatonin in the proliferation and differentiation of hepatocarcinoma cells. Cell Physiol Biochem 2012;30:1502-16. [PMID: 23235525 DOI: 10.1159/000343338] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xu LT, Zhou ZH, Lin JH, Chen Z, Wang K, Wang P, Zhu XY, Shen YH, Meng ZQ, Liu LM. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma. Eur J Surg Oncol. 2011;37:245-251. [PMID: 21195578 DOI: 10.1016/j.ejso.2010.12.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
22 Zhao M, Wang JP, Pan CC, Li W, Huang ZL, Zhang L, Fang WJ, Jiang Y, Li XS, Wu PH. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement. Eur J Radiol 2012;81:2717-25. [PMID: 22245655 DOI: 10.1016/j.ejrad.2011.10.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
23 Kothamasu P, Kanumur H, Ravur N, Maddu C, Parasuramrajam R, Thangavel S. Nanocapsules: the weapons for novel drug delivery systems. Bioimpacts 2012;2:71-81. [PMID: 23678444 DOI: 10.5681/bi.2012.011] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
24 Chen D, Wang R, Meng X, Yan H, Jiang S, Feng R, Zhu K, Xu X, Dou X, Jin L. Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy. Oncol Lett 2014;8:2298-304. [PMID: 25289109 DOI: 10.3892/ol.2014.2456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
25 Zhang Y, Wang T, Tian Y, Zhang C, Ge K, Zhang J, Chang J, Wang H. Gold nanorods-mediated efficient synergistic immunotherapy for detection and inhibition of postoperative tumor recurrence. Acta Pharm Sin B 2021;11:1978-92. [PMID: 34386332 DOI: 10.1016/j.apsb.2021.03.035] [Reference Citation Analysis]
26 Zheng S, Chang S, Lu J, Chen Z, Xie L, Nie Y, He B, Zou S, Gu Z. Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo. PLoS One 2011;6:e21064. [PMID: 21695227 DOI: 10.1371/journal.pone.0021064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
27 Zhang J, Jiang TY, Jiang BG, Yang C, Tan YX, Yang N, Pan YF, Ding ZW, Yang GZ, Wu MC, Dong LW, Wang HY. RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma. Oncotarget 2015;6:3432-42. [PMID: 25605019 DOI: 10.18632/oncotarget.3092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
28 Khorshidi A, Ahmadinejad M, Hamed Hosseini S. Evaluation of a Proposed Biodegradable 188Re Source for Brachytherapy Application: A Review of Dosimetric Parameters. Medicine (Baltimore) 2015;94:e1098. [PMID: 26181543 DOI: 10.1097/MD.0000000000001098] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Scoparo CT, Valdameri G, Worfel PR, Guterres FALB, Martinez GR, Winnischofer SMB, Di Pietro A, Rocha MEM. Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity. Mol Cell Biochem 2015;409:123-33. [DOI: 10.1007/s11010-015-2518-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
30 Fischer K, Gedroyc W, Jolesz FA. Focused ultrasound as a local therapy for liver cancer. Cancer J 2010;16:118-24. [PMID: 20404608 DOI: 10.1097/PPO.0b013e3181db7c32] [Cited by in Crossref: 56] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
31 Kadri H, Blank S, Wang Q, Kim K, Fiel M, Luan W, Hiotis S. Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis B and minimally fibrotic liver. European Journal of Surgical Oncology (EJSO) 2013;39:1371-6. [DOI: 10.1016/j.ejso.2013.09.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
32 Liang Y, Li M, Huang Y, Guo B. An Integrated Strategy for Rapid Hemostasis during Tumor Resection and Prevention of Postoperative Tumor Recurrence of Hepatocellular Carcinoma by Antibacterial Shape Memory Cryogel. Small 2021;:e2101356. [PMID: 34382336 DOI: 10.1002/smll.202101356] [Reference Citation Analysis]
33 Ma B, Jiang H, Jia J, Di L, Song G, Yu J, Zhu Y, Lu Z, Wang X, Zhou X, Ren J. Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells. Clin Transl Oncol 2012;14:764-73. [PMID: 22855153 DOI: 10.1007/s12094-012-0860-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
34 Ng PKS, Lau CPY, Lam EKY, Li SSK, Lui VWY, Yeo W, Ng YK, Lai PBS, Tsui SKW. Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis. Dig Dis Sci 2018;63:676-86. [DOI: 10.1007/s10620-018-4929-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
35 Zhao H, Song Q, Zheng C, Zhao B, Wu L, Feng Q, Zhang Z, Wang L. Implantable Bioresponsive Nanoarray Enhances Postsurgical Immunotherapy by Activating Pyroptosis and Remodeling Tumor Microenvironment. Adv Funct Mater 2020;30:2005747. [DOI: 10.1002/adfm.202005747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
36 Zheng SZ, Sun P, Wang JP, Liu Y, Gong W, Liu J. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. World J Gastroenterol 2019; 25(22): 2752-2762 [PMID: 31235998 DOI: 10.3748/wjg.v25.i22.2752] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
37 Bo XW, Xu HX, Wang D, Guo LH, Sun LP, Li XL, Zhao CK, He YP, Liu BJ, Li DD, Zhang K. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol 2016;89:20160379. [PMID: 27626506 DOI: 10.1259/bjr.20160379] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
38 Santos NP, Colaço AA, Oliveira PA. Animal models as a tool in hepatocellular carcinoma research: A Review. Tumour Biol 2017;39:1010428317695923. [PMID: 28347231 DOI: 10.1177/1010428317695923] [Cited by in Crossref: 46] [Cited by in F6Publishing: 54] [Article Influence: 9.2] [Reference Citation Analysis]
39 Liu S, Zhou G, Liu D, Xie Z, Huang Y, Wang X, Wu W, Jing X. Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers. J Mater Chem B 2013;1:101-9. [DOI: 10.1039/c2tb00121g] [Cited by in Crossref: 70] [Cited by in F6Publishing: 6] [Article Influence: 7.8] [Reference Citation Analysis]
40 Katsuta E, Tanaka S, Mogushi K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Tanabe M, Arii S. Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma. The American Journal of Surgery 2014;208:450-6. [DOI: 10.1016/j.amjsurg.2014.01.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
41 Iezzi R, Pompili M, Posa A, Coppola G, Gasbarrini A, Bonomo L. Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art. World J Gastroenterol 2016; 22(6): 1935-1942 [PMID: 26877601 DOI: 10.3748/wjg.v22.i6.1935] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
42 Chen X, Zhuang J, Kolb JF, Schoenbach KH, Beebe SJ. Long term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fields. Technol Cancer Res Treat. 2012;11:83-93. [PMID: 22181334 DOI: 10.7785/tcrt.2012.500237] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
43 Hooi FM, Nagle A, Subramanian S, Douglas Mast T. Analysis of tissue changes, measurement system effects, and motion artifacts in echo decorrelation imaging. J Acoust Soc Am 2015;137:585-97. [PMID: 25697993 DOI: 10.1121/1.4906580] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
44 Tang S, Bai C, Yang P, Chen X. 14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP. J Proteome Res 2013;12:2511-24. [PMID: 23590642 DOI: 10.1021/pr301085c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
45 Sun H, Yang S, Li J, Zhang Y, Gao D, Zhao S. Caspase-independent cell death mediated by apoptosis-inducing factor (AIF) nuclear translocation is involved in ionizing radiation induced HepG2 cell death. Biochemical and Biophysical Research Communications 2016;472:137-43. [DOI: 10.1016/j.bbrc.2016.02.082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
46 Renzulli M, Tovoli F, Clemente A, Ierardi AM, Pettinari I, Peta G, Marasco G, Festi D, Piscaglia F, Cappabianca S, Carrafiello G, Golfieri R. Ablation for hepatocellular carcinoma: beyond the standard indications. Med Oncol 2020;37:23. [PMID: 32166482 DOI: 10.1007/s12032-020-01348-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Lee TF, Chao PJ, Fang FM, Su TJ, Leung SW, Hsu HC. Helical tomotherapy for single and multiple liver tumours. Radiat Oncol 2010;5:58. [PMID: 20576108 DOI: 10.1186/1748-717X-5-58] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]